Extracellular Vesicles as Next-Generation Diagnostics and Advanced Therapy Medicinal Products
International Journal of Molecular Sciences · 13.06.2024 · 25 (12) · 6533
DOI: 10.3390/ijms25126533 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.06.2024. Verfasst von Agnieszka Stawarska und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology and Food Science, Faculty of Pharmacy, Medical University of Warsaw, Banacha Str. 1, 02-097 Warsaw, Poland. Hauptthemen laut MEDLINE: Extracellular Vesicles. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Centre for Research and Development, Norwegian Financial Mechanisms 2014–2021/POLNOR 2019 (EEA and Norway Grants).
Abstract (Originalsprache)
Extracellular vesicles (EVs) hold great promise for clinical application as new diagnostic and therapeutic modalities. This paper describes major GMP-based upstream and downstream manufacturing processes for EV large-scale production, also focusing on post-processing technologies such as surface bioengineering and uploading studies to yield novel EV-based diagnostics and advanced therapy medicinal products. This paper also focuses on the quality, safety, and efficacy issues of the bioengineered EV drug candidates before first-in-human studies. Because clinical trials involving extracellular vesicles are on the global rise, this paper encompasses different clinical studies registered on clinical-trial register platforms, with varying levels of advancement, highlighting the growing interest in EV-related clinical programs. Navigating the regulatory affairs of EVs poses real challenges, and obtaining marketing authorization for EV-based medicines remains complex due to the lack of specific regulatory guidelines for such novel products. This paper discusses the state-of-the-art regulatory knowledge to date on EV-based diagnostics and medicinal products, highlighting further research and global regulatory needs for the safe and reliable implementation of bioengineered EVs as diagnostic and therapeutic tools in clinical settings. Post-marketing pharmacovigilance for EV-based medicinal products is also presented, mainly addressing such topics as risk assessment and risk management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Toxicology and Food Science, Faculty of Pharmacy, Medical University of Warsaw, Banacha Str. 1, 02-097 Warsaw, Poland.
- Health Effects Laboratory, Department of Environmental Chemistry, Norwegian Institute for Air Research, 2007 Kjeller, Norway.
- Biomaterials-Department of Clinical Dentistry, Faculty of Medicine, University of Bergen, Årstadveien Str. 19, 5009 Bergen, Norway.
ORCID-Profile: Agnieszka Stawarska, Magdalena Bamburowicz-Klimkowska, Elise Runden-Pran, Maria Dusinska, Ivan Rios-Mondragon, Ireneusz P Grudzinski
Förderung
- National Centre for Research and Development
- Norwegian Financial Mechanisms 2014–2021/POLNOR 2019 (EEA and Norway Grants)
Zitieren
APA
Stawarska, A., Bamburowicz-Klimkowska, M., Runden-Pran, E., Dusinska, M., Cimpan, M. R., Rios-Mondragon, I., & Grudzinski, I. P. (2024). Extracellular Vesicles as Next-Generation Diagnostics and Advanced Therapy Medicinal Products. International Journal of Molecular Sciences, 25(12), 6533. https://doi.org/10.3390/ijms25126533
Vancouver
Stawarska A, Bamburowicz-Klimkowska M, Runden-Pran E, Dusinska M, Cimpan MR, Rios-Mondragon I, et al. Extracellular Vesicles as Next-Generation Diagnostics and Advanced Therapy Medicinal Products. International Journal of Molecular Sciences. 2024;25(12):6533. doi:10.3390/ijms25126533
BibTeX
@article{Stawarska2024,
author = {Stawarska, Agnieszka and Bamburowicz-Klimkowska, Magdalena and Runden-Pran, Elise and Dusinska, Maria and Cimpan, Mihaela Roxana and Rios-Mondragon, Ivan and Grudzinski, Ireneusz P},
title = {Extracellular Vesicles as Next-Generation Diagnostics and Advanced Therapy Medicinal Products},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {12},
pages = {6533},
doi = {10.3390/ijms25126533}
}
EUVIMED